Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: Effects of genetic, demographic and neuropathological variables

Folia Neuropathologica

Volumn 54, Issue 2, 2016, Pages 137-148

  Armstrong, Richard A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Frontotemporal dementia lobar degeneration (FTLD); Kaplan Meier estimator; Survival

Indexed keywords

ADOLESCENT; ADULT; ALZHEIMER DISEASE; ARTICLE; CELL INCLUSION; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPAL SCLEROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; NEURONAL CYTOPLASMIC INCLUSION; PATHOGENESIS; PRESENILE DEMENTIA; PRIMARY PROGRESSIVE APHASIA; TDP 43 PROTEINOPATHY; TEMPORAL LOBE; BRAIN; DEMOGRAPHY; GENETICS; INFANT; MORTALITY; MUTATION; NERVE CELL; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; TDP-43 PROTEINOPATHIES; YOUNG ADULT;

DNA BINDING PROTEIN;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; BRAIN; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCLUSION BODIES; INFANT; MALE; MUTATION; NEURONS; TDP-43 PROTEINOPATHIES; YOUNG ADULT;

EID: 84976426684     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2016.60391     Document Type: Article

References (67)

1. Amandor-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007; 61: 435-445.
2. Armstrong RA. Correlations between the morphology of difuse and primitive β-amyloid (Aβ) deposits and the frequency of associated cells in Down's syndrome. Neuropath Appl Neurobiol 1996; 22: 527-530.
3. Armstrong RA. Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology 2003; 42: 521-529.
4. Armstrong RA. A quantitative study of abnormally enlarged neurons in cognitively normal brain and neurodegenerative disease. Clin Neuropathol 2013; 32: 128-134.
5. Armstrong RA. Factors determining disease duration in Alzheimer's disease: A postmortem study of 103 cases using the Kaplan-Meir estimator and Cox regression. Biomed Intern 2014; Article ID: 623487.
6. Armstrong RA, Hilton AC. Statistical analysis in microbiology: Statnotes. Wiley-Blackwell, Hoboken, New Jersey 2011.
7. Armstrong RA, Cairns NJ. Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders. J Neural Transm 2012; 119: 1551-1560.
8. Armstrong RA, Myers D, Smith CUM. Alzheimer's disease: size class frequency distributions of senile plaques: do they indicate when a brain tissue was affected? Neurosci Lett 1991; 127: 223-226.
9. Armstrong RA, Ironside J, Lantos PL, Cairns NJ. A quantitative study of the pathological changes in the cerebellum of 15 cases of variant Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2009; 35: 36-45.
10. Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman A P, Cairns NJ. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 2010; 117: 227-239.
11. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-919.
12. Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015; 386: 1672-1682.
13. Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, Carter D, Paulsmeyer K, Taylor-Reinwald L, Gitcho M, Norton JB, Chakraverty S, Goate AM, Morris JC, Cairns NJ. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alz Dis Assoc Disord 2007; 21: 1-7.
14. Bowen JD, Malter AD, Shepperd L, Kukull WA, McCormick WC, Teri L, Larson EB. Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 1996; 47: 433-439.
15. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
16. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
17. Brodaty H, K. Seeher K, Gibson L. Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Intern Psychogeriatr 2012; 24: 1034-1045.
18. Bruandet A, Richard F, Bombois S, Maurage CA, Masse I, Amouyel P, Pasquier F. Cognitive decline and survival in Alzheimer's disease according to education level. Dement Cog Geriatr 2008; 25: 74-80.
19. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL III, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Steiber A, Xu Y, Forman MS, Trojanowski JQ, Lee VMY, Mackenzie IRA. TDP-43 familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007; 171: 227-240.
20. Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DMA. Neuropathologic diagnostic and nosological criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 5-22.
21. Claus JJ, van Gool WA, Teunisse S, Walstra GJM, Kwa VIH, Hijdra A, Verbeeten B, Koelman JHTM, Bour LJ, De Visser BWO. Predicting survival in patients with early Alzheimer's disease. Dem Cogn Geriatr 1998; 9: 284-293.
22. Coppus AMW, Evenhuis HM, Verberne GJ, Visser FE, Oostra BA, Eikelenboom P, van Gool WA, Janssens ACJW, van Duijn CM. Survival in elderly persons with Down's syndrome. Am Geriatr Soc 2008; 6: 2311-2316.
23. Cruts M, Gijselink I, van der ZJ, Engelborgs S, Wils H, Pirici D, Radamakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De pooter T, Mattheijssens M, van den BM, Cuijt I, Vennekens K, De Deyn P P, Kumar-Singh S, Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-924.
24. Davidson Y, Kelley T, Mackenzie IRA, Pickering Brown S, Du Plessis D, Neary D, Snowden JS, Mann DMA. Ubiquinated pathological lesions in frontotemporal lobar degeneration contain TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007; 113: 521-533.
25. De Lacoste M, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 1993; 14: 1-16.
26. Doody R, Pavlik V, Massman P, Kenan M, Yeh S, Powell S, Cooke N, Dyer C, demirovic J, waring S, Chan WY. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dem Cogn Geriatr 2005; 20: 198-208.
27. Feldman HH, Pirttila T, Dartigues J F, Everitt B, van Baelen B, Brashear HR, Berlin JA, Battisti W P, Kavanagh S. Analysis of mortality risk in patients with dementia treated with galantamine. Acta Neurol Scand 2009; 119: 22-31.
28. Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestrvik A, Smith TN, Tu PH, Watts GDJ, Markesbery WR, Smith CD, Kimonis VE. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 2006; 65: 571-581.
29. Gambassi G, Lapane KL, Landi F, Sgaderi A, Mor V, Bernabel R. Sex differences in the relation between co-morbidity and mortality of patients with Alzheimer's disease. Neurology 1999; 53: 508-516.
30. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010; 33: 317-325.
31. Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao GH, Hladik C, Mantanona TY, White CL. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: A Midwest-Southwest Consortium for FTLD-U study. J Neuropathol Exp Neurol 2008; 67: 271-279.
32. Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology 2003; 61: 349-354.
33. Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, Nestor PJ, Patterson K. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 2010; 133: 300-306.
34. Josephs KA, Knopman DS, Whitwell JL, Boeve B F, Parisi JE, Petersen RC, Dickson DW. Survival in the two variants of tau negative FTLD: FTLD-U versus FTLD-MND. Neurology 2005; 65: 645-647.
35. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW. Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 2006; 63: 1632-1638.
36. Kay DWK, Forster D P, Newens AJ. Long-term survival, place of death, and death certification in clinically diagnosed pre-senile dementia in northern England: follow-up after 8-12 years. Brit J Psychiatr 2000; 177: 156-162.
37. Kersaitis C, Holliday GM, Xuereb JH, Pamphlett R, Bak TH, Hodges JR, Kril JJ. Ubiquitin-positive inclusions and progression of pathology in FTD and MND identifies a group with mainly early pathology. Neuropathol Appl Neurobiol 2006; 32: 83-91.
38. Kovari E, Gold G, Giannakopoulos P, Bouras C. Cortical ubiquitin positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Acta Neuropathol 2004; 108: 207-212.
39. Luty AA, Kwok JBJ, Thompson EM, Blumsbergs P, Brooks WS, Loy CT, Dobson-Stone C, Panegyres PK, Hecker J, Nicholson GA, Halliday GM, Schofield PR. Pedigree with frontotemporal lobar degeneration-motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurology 2008; 8: 32.
40. Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH, Neary D, Snowden JS, Mann DMA. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 2006; 112: 539-549.
41. Mackenzie IRA, Baker M, Pickering-Brown S, Hsinng GYR, Lindholm C, Dwosh E, Cannon A, Rademakers R, Hutton M, Feldman HH. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006; 129: 3081-3090.
42. Mann DMA, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989; 89: 169-179.
43. Mann DMA, Younis N, Jones D, Stoddart RW. The time course of the pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1992; 1: 201-215.
44. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes J P, van Belle G, Berg L et al. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
45. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 1989; 77: 535-546.
46. Mukherjee O, Pastor P, Cairns NJ, Chakraaverty S, Kauwe JSK, Shears S, Behrens MI, Budde J, Hinrichs AL, Norton J, Levitch D, Taylor-Reinwald L, Gitcho M, Tu PH, Grinberg LT, Liscic RM, Armendariz J, Morris JC, Goate AM. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 2006; 60: 314-322.
47. Musicco M, Salamone G, Caltagirone C, Cravello L, Fadda L, Lupio F, Mosti S, Perri R, Palmer K. Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dem Cogn Geriatr 2010; 30: 219-228.
48. Nitrini R, Caramelli P, Herrera E, de Castro I, Bahia VS, Anghinah R, Caixeta L F, Radanovic M, Charchat-Fichman H, Porto CS, Carthery MT, Hartmann APJ, Huang N, Smid J, Lima E P, Takahashi DY, Takada LT. Mortality from dementia in a community dwelling Brazilian population. Int J Geriatr Psych 2005; 20: 247-253.
49. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci U S A 1985; 82: 4531-4534.
50. Pirici D, Vandenberghe R, Rademakers R, Dermant B, Cruts M, Vennekens K, Cuijt I, Lubke U, Centerick C, Martin JJ, Van Broeckhoven C, Kumar-Singh S. Characterization of ubiquinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. J Neuropath Exp Neurol 2006; 65: 289-301.
51. Rademakers R, Hutton M. The genetics of frontotemporal lobar degeneration. Curr Neurol Neurosci Rep 2007; 7: 434-442.
52. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetou A, Abramzon Y, Remes AM, Kaganovitch A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Ricahrdson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kalvorinne AL, Hölttä-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, chio A, Restagno G, Borghero G, Sabatelli M, The ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-268.
53. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, Bruce J, Grossman M, Trojanowski JQ, Lee VM. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immonohistochemistry and novel monoclonal antibodies. Am J Pathol 2006; 189: 1343-1352.
54. Schmidt C, Haik S, Satoh K, Rabano A, Martinez-Martin P, Roeber S, Brandel J P, de Pedro-Cuesta J, Laplanche JL, Kretzschmar H, Zerr I. Rapidly progressive Alzheimer's disease: a multicenter update. J Alz Dis 2010; 30: 751-756.
55. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007; 114: 31-38.
56. Staff RT, Murray AD, Ahearn T, Salarirad S, MOwat D, Starr JM, Deary IJ, Lemmon H, Whalley LJ. Brain volume and survival from age 78 to 85: the contribution of Alzheimer-type magnetic resonance imaging findings. J Am Geriatr 2010; 58: 688-695.
57. Steiner JA, Angot E, Brunden P. A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ 2011; 18: 1425-1433.
58. Thalhauser CJ, Komarova NL. Alzheimer's disease: rapid and slow progression. J Roy Soc 2012; 9: 119-126.
59. Tolnay M, Probst A. Frontotemporal lobar degeneration - tau as a pied piper? Neurogenetics 2002; 4: 63-75.
60. Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y. Factors associated with mortality in patients with early-onset Alzheimer's disease: a five year longitudinal study. Int J Geriatr Psych 2001; 16: 810-815.
61. Van Deerlin VM, Wood EM, Moore P, Yuan W, Forman MS, Clark CM, Neumann M, Kwong LK, Trojanowski JQ, Lee VMY, Grossman M. Clinical, genetic and pathologic characteristics of patients with frontotemporal dementia and progranulin mutation. Arch Neurol 2007; 64: 1148-1153.
62. Weiner MF, Risser RC. Effect of educational attainment on survival in Alzheimer's disease. Alzheim Rep 1998; 1: 369-374.
63. Whitwell JL, Jack CR, Serijeni ML, Josephs KA. Patterns of atrophy in pathologically confirmed FTLD with or without motor neuron degeneration. Neurology 2006; 66: 102-104.
64. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquinated cytoplasmic and intranuclear inclusions. Acta Neuro pathol 2001; 102: 94-102.
65. Yaguchi M, Fujita Y, Amari M, Takatama M, Al-Sarraj S, Leigh PN, Okamoto K. Morphological differences of intraneural ubiquitin positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology 2004; 24: 296-301.
66. Zekry D, Herrmann FR, C.E. Graf. CE, Gianelli S, Michel J P, Gold G, Krause KH. High levels of co-morbidity and disability cancel out the dementia effect in predictions of long-term mortality after discharge in the very old. Dem Cogn Geriatr 2011; 32: 103-110.
67. Zhou B, Zhao QH, Teramukai S, Ding D, Guo QH, Fukushimna M. Executive function predicts survival in Alzheimer's disease. J Alz Dis 2010; 22: 673-682.